Sequent Medical Inc., an Aliso Viejo medical device maker, said Thursday it raised $15.6 million in a second round of venture financing.
Sequent, which was established in 2007, is working on devices to treat ballooning blood vessels in the brain. It was started by Bob Rosenbluth and Brian Cox, who previously owned MicroVention Inc., a device maker that’s now part of Japan’s Terumo Corp.
Thomas Wilder, Sequent’s chief executive, said in a statement that it would use the money to continue funding its development programs.
Domain Associates, a venture capital firm with offices in Princeton, N.J. and San Diego, led the funding. Versant Venture Management LLC, which has an office in Newport Beach, and US Venture Partners of Menlo Park also participated.
As part of the funding, Sequent said that Nimesh Shah, a principal at Domain, became part of its board of directors. Sequent’s board also includes Donald Milder, a Versant managing director.
